Knowledge and attitude of general pratictioners towards direct-to-consumer genomic tests: A survey conducted in Italy

Anna Baroncini, Calabrese Olga, Colotto Marco, Pelo Elisabetta, Torricelli Francesca, Boccia Stefania

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND: Personal genomic tests (PGT) offered directly-to-consumers (DTC) for complex disease risk assessment have raised several concerns regarding their potential adverse impact. To mitigate worries continuing professional education has been advocated and the central gatekeeper role of family physicians has been highlighted. Nevertheless, to date, only few studies have been published on awareness, involvement and attitudes of primary healthcare providers on DTC marketing of PGT and, to the best of our knowledge, none in Italy. METHODS: An exploratory survey to achieve information about knowledge and attitudes towards DTCPGT of a selected group of family physicians participating to courses on predictive medicine and public health genomics was conducted. RESULTS: A total amount of 114 partially or fully filled questionnaires was obtained. The majority of the primary care providers (68,4%) expressed that they are unaware that companies are selling genomic tests directly to consumers, while 31,6% was aware. In terms of attitudes toward testing 61,1% of the aware respondents deemed the DTC-PGT for chronic complex diseases to be "not clinically useful." The overwhelming majority of our respondents (95,6%) felt unprepared to answer patients’ questions on DTC-PGT. If only aware respondents are considered this percentage results obviously lower (86,1%), though still very high. CONCLUSION: The low percentage of aware respondents suggests that DTC advertising in the realm of genomic testing is still limited in Italy. Should DTC-PGT become more widely used, a comprehensive education program may be necessary to increase family physicians’ awareness and help them discuss testing with their patients.

Original languageEnglish
Article numbere11613
JournalEpidemiology Biostatistics and Public Health
Volume12
Issue number4
DOIs
Publication statusPublished - 2015

Fingerprint

Italy
Family Physicians
Primary Health Care
Professional Education
Continuing Education
Genomics
Marketing
Health Personnel
Surveys and Questionnaires
Chronic Disease
Public Health
Medicine
Education

Keywords

  • Direct-to-consumer
  • Genomic test
  • Health professionals
  • Knowledge

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Public Health, Environmental and Occupational Health
  • Community and Home Care

Cite this

Knowledge and attitude of general pratictioners towards direct-to-consumer genomic tests : A survey conducted in Italy. / Baroncini, Anna; Olga, Calabrese; Marco, Colotto; Elisabetta, Pelo; Francesca, Torricelli; Stefania, Boccia.

In: Epidemiology Biostatistics and Public Health, Vol. 12, No. 4, e11613, 2015.

Research output: Contribution to journalArticle

Baroncini, Anna ; Olga, Calabrese ; Marco, Colotto ; Elisabetta, Pelo ; Francesca, Torricelli ; Stefania, Boccia. / Knowledge and attitude of general pratictioners towards direct-to-consumer genomic tests : A survey conducted in Italy. In: Epidemiology Biostatistics and Public Health. 2015 ; Vol. 12, No. 4.
@article{1e24c4fd54ae45f1a22e5374ca383cdb,
title = "Knowledge and attitude of general pratictioners towards direct-to-consumer genomic tests: A survey conducted in Italy",
abstract = "BACKGROUND: Personal genomic tests (PGT) offered directly-to-consumers (DTC) for complex disease risk assessment have raised several concerns regarding their potential adverse impact. To mitigate worries continuing professional education has been advocated and the central gatekeeper role of family physicians has been highlighted. Nevertheless, to date, only few studies have been published on awareness, involvement and attitudes of primary healthcare providers on DTC marketing of PGT and, to the best of our knowledge, none in Italy. METHODS: An exploratory survey to achieve information about knowledge and attitudes towards DTCPGT of a selected group of family physicians participating to courses on predictive medicine and public health genomics was conducted. RESULTS: A total amount of 114 partially or fully filled questionnaires was obtained. The majority of the primary care providers (68,4{\%}) expressed that they are unaware that companies are selling genomic tests directly to consumers, while 31,6{\%} was aware. In terms of attitudes toward testing 61,1{\%} of the aware respondents deemed the DTC-PGT for chronic complex diseases to be {"}not clinically useful.{"} The overwhelming majority of our respondents (95,6{\%}) felt unprepared to answer patients’ questions on DTC-PGT. If only aware respondents are considered this percentage results obviously lower (86,1{\%}), though still very high. CONCLUSION: The low percentage of aware respondents suggests that DTC advertising in the realm of genomic testing is still limited in Italy. Should DTC-PGT become more widely used, a comprehensive education program may be necessary to increase family physicians’ awareness and help them discuss testing with their patients.",
keywords = "Direct-to-consumer, Genomic test, Health professionals, Knowledge",
author = "Anna Baroncini and Calabrese Olga and Colotto Marco and Pelo Elisabetta and Torricelli Francesca and Boccia Stefania",
year = "2015",
doi = "10.2427/11613",
language = "English",
volume = "12",
journal = "Epidemiology Biostatistics and Public Health",
issn = "2282-2305",
publisher = "Prex",
number = "4",

}

TY - JOUR

T1 - Knowledge and attitude of general pratictioners towards direct-to-consumer genomic tests

T2 - A survey conducted in Italy

AU - Baroncini, Anna

AU - Olga, Calabrese

AU - Marco, Colotto

AU - Elisabetta, Pelo

AU - Francesca, Torricelli

AU - Stefania, Boccia

PY - 2015

Y1 - 2015

N2 - BACKGROUND: Personal genomic tests (PGT) offered directly-to-consumers (DTC) for complex disease risk assessment have raised several concerns regarding their potential adverse impact. To mitigate worries continuing professional education has been advocated and the central gatekeeper role of family physicians has been highlighted. Nevertheless, to date, only few studies have been published on awareness, involvement and attitudes of primary healthcare providers on DTC marketing of PGT and, to the best of our knowledge, none in Italy. METHODS: An exploratory survey to achieve information about knowledge and attitudes towards DTCPGT of a selected group of family physicians participating to courses on predictive medicine and public health genomics was conducted. RESULTS: A total amount of 114 partially or fully filled questionnaires was obtained. The majority of the primary care providers (68,4%) expressed that they are unaware that companies are selling genomic tests directly to consumers, while 31,6% was aware. In terms of attitudes toward testing 61,1% of the aware respondents deemed the DTC-PGT for chronic complex diseases to be "not clinically useful." The overwhelming majority of our respondents (95,6%) felt unprepared to answer patients’ questions on DTC-PGT. If only aware respondents are considered this percentage results obviously lower (86,1%), though still very high. CONCLUSION: The low percentage of aware respondents suggests that DTC advertising in the realm of genomic testing is still limited in Italy. Should DTC-PGT become more widely used, a comprehensive education program may be necessary to increase family physicians’ awareness and help them discuss testing with their patients.

AB - BACKGROUND: Personal genomic tests (PGT) offered directly-to-consumers (DTC) for complex disease risk assessment have raised several concerns regarding their potential adverse impact. To mitigate worries continuing professional education has been advocated and the central gatekeeper role of family physicians has been highlighted. Nevertheless, to date, only few studies have been published on awareness, involvement and attitudes of primary healthcare providers on DTC marketing of PGT and, to the best of our knowledge, none in Italy. METHODS: An exploratory survey to achieve information about knowledge and attitudes towards DTCPGT of a selected group of family physicians participating to courses on predictive medicine and public health genomics was conducted. RESULTS: A total amount of 114 partially or fully filled questionnaires was obtained. The majority of the primary care providers (68,4%) expressed that they are unaware that companies are selling genomic tests directly to consumers, while 31,6% was aware. In terms of attitudes toward testing 61,1% of the aware respondents deemed the DTC-PGT for chronic complex diseases to be "not clinically useful." The overwhelming majority of our respondents (95,6%) felt unprepared to answer patients’ questions on DTC-PGT. If only aware respondents are considered this percentage results obviously lower (86,1%), though still very high. CONCLUSION: The low percentage of aware respondents suggests that DTC advertising in the realm of genomic testing is still limited in Italy. Should DTC-PGT become more widely used, a comprehensive education program may be necessary to increase family physicians’ awareness and help them discuss testing with their patients.

KW - Direct-to-consumer

KW - Genomic test

KW - Health professionals

KW - Knowledge

UR - http://www.scopus.com/inward/record.url?scp=84951304318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951304318&partnerID=8YFLogxK

U2 - 10.2427/11613

DO - 10.2427/11613

M3 - Article

AN - SCOPUS:84951304318

VL - 12

JO - Epidemiology Biostatistics and Public Health

JF - Epidemiology Biostatistics and Public Health

SN - 2282-2305

IS - 4

M1 - e11613

ER -